| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/17/2000 | CA2338855A1 Indole spla2 inhibitors |
| 02/17/2000 | CA2338727A1 Indole spla2 inhibitors |
| 02/17/2000 | CA2338385A1 Human receptor-associated proteins |
| 02/17/2000 | CA2338121A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 02/17/2000 | CA2338035A1 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 02/16/2000 | EP0979870A1 Human Wnt-6 polypeptide |
| 02/16/2000 | EP0979869A1 Short oligonucleotides for the inhibition of VEGF expression |
| 02/16/2000 | EP0979822A1 Process for the preparation of 2-carbamoyl-pyridines |
| 02/16/2000 | EP0979289A1 Human lysophospholipase |
| 02/16/2000 | EP0979240A1 Serine protease inhibitors |
| 02/16/2000 | EP0979230A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
| 02/16/2000 | EP0979122A1 Targeted therapy to a biomedical device |
| 02/16/2000 | EP0979096A1 Treatment of infarcts through inhibition of nf-kappab |
| 02/16/2000 | EP0979094A2 Agent for enhancing the heart force |
| 02/16/2000 | EP0979084A1 Use of anabolic steroid derivatives in the treatment of chronic heart failure |
| 02/16/2000 | EP0979078A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 02/16/2000 | EP0979077A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders |
| 02/16/2000 | EP0802900B1 Antiarrhythmic (s)-enantiomers of methanesulfonamides |
| 02/16/2000 | CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 02/16/2000 | CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase |
| 02/16/2000 | CN1244864A 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists |
| 02/16/2000 | CN1244862A Endothelin antagonists: N-[[2'-[[4,5-dimethyl-3-isoxazolyl) amino] sulfonyl]-4-(2-oxazolyl) [1,1'-biphenyl]-2-yl] methyl] |
| 02/16/2000 | CN1244528A Di- Or triaza-spiral [4,5] decane derivative |
| 02/16/2000 | CN1244525A Substituted dihydropyridine dicarboxylic ester |
| 02/16/2000 | CN1244427A Anal fistula ointment and its compounding process |
| 02/16/2000 | CN1049431C Morpholine derivative and its use and medicinal prepration containing said derivatives |
| 02/16/2000 | CN1049430C Sulfonamides and its preparing method and use thereof |
| 02/16/2000 | CN1049428C Short-acting dihydropyridines compounds and its preparing method and use |
| 02/15/2000 | US6025500 Heterogeneous catalytic reductive amination between alanylproline and ethyl-2-oxo-4-phenylbutyrate |
| 02/15/2000 | US6025494 Tetracyclic derivatives, process of preparation and use |
| 02/15/2000 | US6025396 Stable prostaglandin E1-containing injectable composition |
| 02/15/2000 | US6025388 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
| 02/15/2000 | US6025381 3,4-(diphenyl)chromans |
| 02/15/2000 | US6025378 Antiatherosclerotic action. |
| 02/15/2000 | US6025375 4,5-diaryloxazole derivatives |
| 02/15/2000 | US6025373 Decreasing fibrinogen levels without undohypo-coagulation, |
| 02/15/2000 | US6025372 Somatostatin agonists |
| 02/15/2000 | US6025369 N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis |
| 02/15/2000 | US6025349 Phenyl.-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them |
| 02/15/2000 | US6025334 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
| 02/15/2000 | US6025331 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |
| 02/15/2000 | US6025325 Pegylated obese (ob) protein compositions |
| 02/15/2000 | US6025196 Chimeric proteins comprising liver enriched transcription factors and nucleic acids encoding the same |
| 02/15/2000 | US6025166 Human trk receptors and neurotrophic factor inhibitors |
| 02/15/2000 | US6025142 Hydrophobic u-PAR binding site |
| 02/15/2000 | US6024936 Antibody-based method of localizing activated thrombin receptors |
| 02/15/2000 | CA2197739C 1,4-dihydropyridine compounds |
| 02/15/2000 | CA2077461C Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway |
| 02/12/2000 | CA2248989A1 Novel compounds |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006709A1 Human protein kinase h2lau20 |
| 02/10/2000 | WO2000006701A1 Improvement of cardiac function by mesenchymal stem cell transplantation |
| 02/10/2000 | WO2000006698A1 98 human secreted proteins |
| 02/10/2000 | WO2000006601A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | WO2000006589A1 Prostate derived ets factor |
| 02/10/2000 | WO2000006570A1 Triazolopyridines for the treatment of thrombosis disorders |
| 02/10/2000 | WO2000006569A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 02/10/2000 | WO2000006568A1 Substituted pyrazole derivatives |
| 02/10/2000 | WO2000006567A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine |
| 02/10/2000 | WO2000006563A1 Substituted imidazoles having cytokine inhibitory activity |
| 02/10/2000 | WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | WO2000006558A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 02/10/2000 | WO2000006297A1 Compound storage |
| 02/10/2000 | WO2000006206A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | WO2000006199A1 Kvlqt1 - a long qt syndrome gene |
| 02/10/2000 | WO2000006195A1 Targeting pharmaceutical agents to injured tissues |
| 02/10/2000 | WO2000006187A2 Modulation of apoptosis |
| 02/10/2000 | WO2000006185A2 Methods of using lanreotide, a somatostatin analogue |
| 02/10/2000 | WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT |
| 02/10/2000 | WO2000006174A1 Methods for increasing cytidine levels in vivo and treating cytidine-dependent human diseases |
| 02/10/2000 | WO2000006153A1 Propenamides as ccr5 modulators |
| 02/10/2000 | WO2000006147A1 Macrophage scavenger receptor antagonists |
| 02/10/2000 | WO2000006145A1 Methods for treating conditions modulated by lactosylceramide |
| 02/10/2000 | WO2000006126A1 Rapidly disintegrable solid preparation |
| 02/10/2000 | WO2000006085A2 Compounds and methods |
| 02/10/2000 | WO2000006032A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | WO2000000510A8 Growth factor modulators |
| 02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
| 02/10/2000 | WO1999045126A3 Enhanced prodrug activation |
| 02/10/2000 | DE19835325A1 Verwendung von Cyclopentabenzofuran-Derivaten zur Bekämpfung von NF-kB abhängigen Krankheiten Use of cyclopentabenzofuran derivatives for the control of NF-kB-dependent diseases |
| 02/10/2000 | DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use |
| 02/10/2000 | CA2581111A1 Rapidly disintegrable solid preparation |
| 02/10/2000 | CA2525555A1 Rapidly disintegrable solid preparation |
| 02/10/2000 | CA2339301A1 Hdpbo81 nucleic acids and polypeptides |
| 02/10/2000 | CA2339096A1 Modulation of apoptosis |
| 02/10/2000 | CA2339094A1 Macrophage scavenger receptor antagonists |
| 02/10/2000 | CA2339071A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 02/10/2000 | CA2338804A1 Propenamides as ccr5 modulators |
| 02/10/2000 | CA2338697A1 Compounds and methods |
| 02/10/2000 | CA2338694A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 02/10/2000 | CA2338654A1 Triazolopyridines for the treatment of thrombosis disorders |
| 02/10/2000 | CA2338396A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | CA2338019A1 Prostate derived ets factor |
| 02/10/2000 | CA2336549A1 Methods for treating conditions modulated by lactosylceramide |
| 02/10/2000 | CA2336543A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | CA2336530A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 02/10/2000 | CA2336263A1 Kvlqt1 - a long qt syndrome |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335654A1 Methods of using a somatostatin analogue |
| 02/10/2000 | CA2335643A1 C7f2-a novel potassium channel .beta.-subunit |